Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Mallinckrodt
Johnson and Johnson
Dow
McKesson

Last Updated: August 15, 2022

ACYCLOVIR; HYDROCORTISONE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for acyclovir; hydrocortisone and what is the scope of patent protection?

Acyclovir; hydrocortisone is the generic ingredient in one branded drug marketed by Bausch and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Acyclovir; hydrocortisone has twenty-five patent family members in twenty-one countries.

One supplier is listed for this compound.

Summary for ACYCLOVIR; HYDROCORTISONE
International Patents:25
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 4
DailyMed Link:ACYCLOVIR; HYDROCORTISONE at DailyMed
Recent Clinical Trials for ACYCLOVIR; HYDROCORTISONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 2
Alphacait, LLCPhase 2
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all ACYCLOVIR; HYDROCORTISONE clinical trials

US Patents and Regulatory Information for ACYCLOVIR; HYDROCORTISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ACYCLOVIR; HYDROCORTISONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 See Plans and Pricing See Plans and Pricing
Bausch XERESE acyclovir; hydrocortisone CREAM;TOPICAL 022436-001 Jul 31, 2009 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ACYCLOVIR; HYDROCORTISONE

Country Patent Number Title Estimated Expiration
Malaysia 122397 ACYCLIC ANTIVIRAL AND HYDROCORTISONE COMBINATION COMPRISING PROPYLENE GLYCOL AND ALKANOIC ACID ESTER See Plans and Pricing
Taiwan 589191 See Plans and Pricing
Spain 2233104 See Plans and Pricing
Canada 2351463 FORMULATIONS ANTIVIRALES RENFERMANT DU PROPYLENE GLYCOL ET UN ESTER ACIDE ALKANOIQUE D'ISOPROPYLE (ANTIVIRAL FORMULATIONS COMPRISING PROPYLENE GLYCOL AND AN ISOPROPYL ALKANOIC ACID ESTER) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Moodys
Harvard Business School
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.